Related Experiment Video
Updated: Jan 15, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
High Triglyceride-Glucose Index Predicts Mortality in Patients with Acute Myocardial Infarction in Intensive Care
Clinical Laboratory
|October 13, 2025
Summary
The triglyceride and glucose (TyG) index may predict mortality in acute myocardial infarction (AMI) patients. A higher TyG index was linked to increased mortality risk, suggesting its use in patient risk stratification.
Area of Science:
- Cardiology
- Metabolic Syndrome
- Clinical Research
Background:
- Metabolic dysregulation, specifically in triglyceride and glucose metabolism, is a known contributor to cardiovascular diseases.
- Acute myocardial infarction (AMI) patients face significant mortality risks, necessitating improved prognostic tools.
Purpose of the Study:
- To investigate the association between the triglyceride and glucose (TyG) index and mortality rates in patients diagnosed with AMI.
- To evaluate the TyG index as a potential predictor for risk stratification in AMI patients.
Main Methods:
- A retrospective cohort study utilized data from the MIMIC-IV database, including 1,123 AMI patients.
- The TyG index was calculated, and multivariate analyses, including Cox proportional hazards regression, were performed, adjusting for confounders like BMI and diabetes status.
Main Results:
- Patients with higher TyG index values exhibited significantly increased hospital, ICU, and all-cause mortality rates.
- Kaplan-Meier survival analysis revealed lower mortality in patients with a low TyG index compared to those with a high TyG index.
- The TyG index independently predicted all-cause mortality in AMI patients (HR 1.884, p=0.007).
Conclusions:
- The triglyceride and glucose (TyG) index shows promise as a predictive marker for mortality in acute myocardial infarction (AMI) patients.
- The TyG index can assist in the clinical risk stratification of AMI patients, particularly those in the ICU.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
219
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
219
Acute Coronary Syndrome III: Diagnostic Studies
213
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
213
Angina IV: Management
236
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
236
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
794
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
794
Acute Coronary Syndrome I: Introduction
804
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
804

